Kezar Life Sciences – (KZR, +N, 23-Mar-22)

Franklin Berger (Non-Executive since 2016) purchased $1.3 million of stock at $16.25 on March 21st, increasing his holding by 10%. This is his first open-market purchase and its size is larger than his two previous subscriptions combined in February and June 2020 at $2.60 and $5.50 respectively.

He has a very good record in Essa Pharma Inc, another pharmaceutical company where he is a director, and made an equally large purchase in August 2020 which was extremely well-timed. The stock has more than doubled over a year and this is interesting to see him making this large purchase.

We are ranking the stock +N.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.